Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial

✍ Scribed by Tremoulet, Adriana H; Jain, Sonia; Jaggi, Preeti; Jimenez-Fernandez, Susan; Pancheri, Joan M; Sun, Xiaoying; Kanegaye, John T; Kovalchin, John P; Printz, Beth F; Ramilo, Octavio; Burns, Jane C

• Book ID: 122318101
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 185 KB
• Volume: 383
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/S0140-6736(13)62298-9